| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587106 | Diabetes Research and Clinical Practice | 2017 | 12 Pages |
Abstract
FRD-induced MS shows reduction in MSC osteogenic potential, in osteocyte density and in TRAP activity. Oral metformin treatment was able to prevent trabecular osteocyte loss and the reduction in extracellular mineralization induced by FRD-induced MS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Juan Ignacio Felice, León Schurman, Antonio Desmond McCarthy, Claudia Sedlinsky, José Ignacio Aguirre, Ana MarÃa Cortizo,